Research Information System
Atlas Journal of Medicine, vol.5, no.12, pp.25-31, 2025 (Peer-Reviewed Journal)
Objective: This study examines the prescription patterns for patients hospitalized following stent implantation for cardiovascular diseases, evaluating these patterns against clinical guidelines and exploring patient demographics, diagnoses, and comorbidities.
Materials and Methods: A cross-sectional study was conducted on 111 patients aged 18-85 years who received stents at a private hospital between January 8, 2021, and October 4, 2021. Data on demographics, diagnoses, and prescriptions were collected retrospectively and analyzed using SPSS software. Diagnoses were categorized according to ICD-10 codes, and medications were classified using the ATC system.
Results: The study included 111 patients, 65% of whom were male, with a mean age of 63.0±10.5 years. Atherosclerotic heart disease (87.4%) and essential hypertension (85.6%) were the most common diagnoses. The most frequently prescribed medications were nitrates (100.0%), dual antiplatelet therapy (99.1%), anticoagulants (97.3%), and statins (87.4%). According to the ATC classification, the most common drug groups were those affecting blood and blood-forming organs (51.0%), the cardiovascular system (23.0%), and the nervous system (13.0%).
Conclusion: The prescribing patterns for stent patients in this study largely adhered to clinical guidelines, particularly regarding the use of dual antiplatelet therapy, nitrates, and anticoagulants. However, variability in some prescription practices indicates a need for ongoing education and review to ensure optimal patient outcomes. This study underscores the importance of guideline-based therapy in the management of coronary artery disease and highlights the complex clinical profiles of patients requiring stent implantation.